Pentapeptide-18 vs Argireline: Expression-Line Peptide Serum Comparison

Ingredient names before trade names

Pentapeptide-18 is often associated with Leuphasyl, while Acetyl Hexapeptide-8 is commonly associated with Argireline. Those trademarks refer to specific commercial materials and evidence packages, not every raw material carrying a similar INCI. Confirm original manufacturer, grade, trademark permission, complete composition and recommended use.

Different materials, similar consumer intent

Both are positioned for the appearance of expression lines, yet their sequences, proposed mechanisms and commercial carriers differ. Mechanistic diagrams are not head-to-head clinical proof. Avoid stating that one relaxes facial muscles in a drug-like manner or that either replaces a neuromodulator injection.

How to make a fair supplier comparison

Normalize active peptide concentration rather than comparing stock-solution percentages. Record water, glycol, humectant, preservative and salt introduced at the proposed dose. Compare specification, identity testing, stability support, batch COA, sample representativeness, MOQ and change notification.

Single-active and combination formulas

A single peptide supports a cleaner evidence story and easier troubleshooting. A combination can address buyer demand for a multi-peptide serum but increases cost and compatibility variables. Use a design-of-experiments approach when possible instead of adding both at maximum supplier use levels.

Texture, pH and processing

Expression-line serums are often light gels intended for targeted areas or full-face use. Control tack and pilling beneath sunscreen or makeup. Follow the most restrictive compatible pH and temperature guidance across all grades, and recheck viscosity after peptide stock solutions are incorporated.

Evidence and claims plan

Establish whether a claim concerns immediate smoothing from film formers and hydration or gradual changes after repeated use. Use a comparator and standardized imaging when making visible-line claims. Ingredient data may support rationale, but finished-product wording requires evidence relevant to the final formula, dose, population and duration.

RFQ fields

Include INCI or specified trade grade, active basis, desired combination, fill size, package, target region, claim wording, fragrance policy, companion actives, sample quantity, MOQ and test plan. Ask the supplier to identify which documents and studies apply to the exact quoted material.

Selected research for further reading

These sources provide context and do not replace finished-product substantiation.

• Recent peptide skin-aging systematic review

Frequently asked B2B question

Can supplier data support the finished-product claim?

Supplier documentation can support ingredient selection and claim rationale, but transferability depends on the exact grade, active dose, vehicle, population, endpoint and use conditions. Material claims should be reviewed separately from claims on the finished cosmetic.